Scientists at the University of Pennsylvania (Penn) and its Perelman School of Medicine in the US have developed an odour-based test to precisely identify hard-to-detect cancers.
In a study, the test was able to detect and differentiate between benign and pancreatic or ovarian cancer cells with an accuracy of up to 95%.
Named e-nose, the test leverages artificial intelligence (AI) and machine learning to interpret the mixture of volatile organic compounds (VOCs) generated by cells in blood plasma samples.
